Refine Results
- 必威体育赛事投注
- Applications and Industries
- Content Type
-
Content Type
- Analysis Platform
-
Product
- Language
-
Language
Applied Filters
To be enabled for e-commerce, you must first register.必威体育登录手机Agilent will then confirm your registration and inform you when your enablement is complete and you can begin transacting.
E-commerce is currently not available in your country.必威体育登录手机For select consumables and supplies you may now use Saved Cart link under your Account to build lists and send to your Agilent Representative.Simply login or register and you may begin.
LC/MS based characterization workflow of the GLP-1 therapeutic peptide liraglutide and its impurities using the 1290 Infinity II LC and 6545XT AdvanceBio LC/Q-TOF.
- Publication Part Number: 5994-7727EN
- Created: 03 Sep 2024
- 3 MB
In this application note, we explore some of the key parameters when comparing different column chemistries using ion-pair reversed-phase (IP-RP) separation of Semaglutide.
- Publication Part Number: 5994-7419EN
- Created: 08 May 2024
- 530 KB
This application note presents an HPLC method development for the purity testing of semaglutide.
- Publication Part Number: 5994-7414EN
- Created: 06 May 2024
- 710 KB
Korean (Korea) | Complete (PDF) |
---|
This application note utilizes the 1260 Infinity II Bio Prime LC and InfinityLab LC/MSD iQ for the confirmation of GLP-1 (Liraglutide) sample.
- Publication Part Number: 5994-7415EN
- Created: 01 May 2024
- 1 MB